Rethinking our public health genetics research paradigm

American Journal of Public Health

Volumn 103, Issue SUPPL.1, 2013, Pages

  El Sayed, Abdulrahman M ^a,b   Koenen, Karestan C ^a   Galea, Sandro ^a  

^a Department of Medicine   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENETICS; GENOTYPE; HUMAN; METHODOLOGY; PHENOTYPE; POPULATION GENETICS; PUBLIC HEALTH;

GENETIC RESEARCH; GENETICS, POPULATION; GENOTYPE; HUMANS; PHENOTYPE; PUBLIC HEALTH; RESEARCH DESIGN;

EID: 84884141010     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.301127     Document Type: Review

References (42)

1. Pohlhaus JR, Cook-Deegan RM. Genomics research: world survey of public funding. BMC Genomics. 2008; 9(1): 472.
2. HuGE Navigator. Available at: http://www.hugenavigator.net. Accessed March 20, 2012.
3. Gwinn M, Grossniklaus DA, Yu W, et al. Horizon scanning for new genomic tests. Genet Med. 2011;13(2): 161-165.
4. National Center for Biotechnology Information. GeneTests. Available at: http://www.genetests.org. Accessed July 8, 2013.
5. van de Vijver MJ, He YD, Van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347(25): 1999-2009.
6. Lloyd-Puryear MA, Brower A. Longterm follow-up in newborn screening: a systems approach for improving health outcomes. Genet Med. 2010;12(12 suppl): S256-S260.
7. Collins FS. The Language of Life: DNA and the Revolution in Personalized Medicine. New York, NY: HarperCollins; 2010.
8. McGowan PO, Sasaki A, D'Alessio AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009;12(3): 342-348.
9. Meaney MJ, Szyf M, Seckl Jr. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol Med. 2007;13(7): 269-277.
10. Szyf M, Weaver I, Meaney M. Maternal care, the epigenome and phenotypic differences in behavior. Reprod Toxicol. 2007;24(1): 9-19.
11. Hardy R, Wills AK, Wong A, et al. Life course variations in the associations between FTO and MC4R gene variants and body size. Hum Mol Genet. 2010;19 (3): 545-552.
12. North KE, Graff M, Adair LS, et al. Genetic epidemiology of BMI and body mass change from adolescence to young adulthood. Obesity (Silver Spring). 2010;18(7): 1474-1476.
13. Khoury MJ, Gwinn M, Bowen MS, Dotson WD. Beyond base pairs to bedside: a population perspective on how genomics can improve health. Am J Public Health. 2012;102(1): 34-37.
14. Khoury MJ, Gwinn M, Burke W, Bowen S, Zimmern R. Will genomics widen or help heal the schism between medicine and public health? Am J Prev Med. 2007;33(4): 310-317.
15. Khoury MJ, McCabe LL, McCabe ERB. Population screening in the age of genomic medicine. N Engl J Med. 2003;348 (1): 50-58.
16. Krieger N. Epidemiology and the People's Health: Theory and Context. New York, NY: Oxford University Press; 2011.
17. Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94 (8): 666-668.
18. Kelley E, Moy E, Stryer D, Burstin H, Clancy C. The national healthcare quality and disparities reports: an overview. Med Care. 2005;43(3):I3-I8.
19. Schlesselman JJ, Stolley PD. Case- Control Studies: Design, Conduct, Analysis. Oxford, UK: Oxford University Press; 1982.
20. Burton PR, Hansell AL, Fortier I, et al. Size matters: just how big is BIG?: quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol. 2009;38(1): 263-273.
21. El-Sayed AM, Haloossim MR, Galea S, Koenen KC. Epigenetic modifications associated with suicide and common mood and anxiety disorders: a systematic review of the literature. Biol Mood Anxiety Disord. 2012;2(1): 10.
22. Rampersaud E,Mitchell BD, Pollin TI, et al. Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch Intern Med. 2008;168(16): 1791-1797.
23. Xie P, Kranzler HR, Poling J, et al. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology. 2010;35(8): 1684-1692.
24. Nikulina V,WidomCS, Brzustowicz LM. Child abuse and neglect, MAOA, and mental health outcomes: a prospective examination. Biol Psychiatry. 2012;71 (4): 350-357.
25. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ionnidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29(3): 306-309.
26. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet. 2003;361(9360): 865-872.
27. Ryan SG. Regression to the truth: replication of association in pharmacogenetic studies. Pharmacogenomics. 2003;4 (2): 201-207.
28. Gambaro G, Anglani F, D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet. 2000;355(9200): 308-311.
29. Taneri B, Ambrosino E, van Os J, Brand A. A new public health genomics model for common complex diseases, with an application to common behavioral disorders. Personalized Med. 2012;9(1): 29-38.
30. The Great Smoky Mountains Study. Available at: http://devepi.duhs.duke. edu/gsms.html. Accessed March 27, 2012.
31. Dunedin Study. Available at: http://dunedinstudy.otago.ac.nz/studies/ mainstudy/description. Accessed May 27, 2012.
32. Atherosclerosis Risk in Communities Study. Available at: http://www.cscc.unc. edu/aric. Accessed August 1, 2012.
33. CARDIA: Coronary Artery Risk Development in Young Adults. Available at: http://www.cardia.dopm.uab.edu. Accessed August 1, 2012.
34. Multi-Ethnic Study of Atherosclerosis. 2012. Available at: http://www.mesanhlbi. org. Accessed August 1, 2012.
35. Detroit Neighborhood Health Study. 2012. Available at: http://detroitneighborhoodhealthstudy.org. Accessed March 27, 2012.
36. Kaiser Permanente. The research program on genes, environment, and health. 2012. Available at: http://www. dor.kaiser.org/external/DORExternal/ rpgeh/index.aspx. Accessed September 4, 2012.
37. Koenen KC, Uddin M, Chang SC, et al. SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depress Anxiety. 2011;28(8): 639-647.
38. McDermott U, Downing JR, Stratton MR. Genomics and the continuum of cancer care. N Engl J Med. 2011;364 (4): 340-350.
39. Wideroff L, Phillips KA, Randhawa G, et al. A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. 2009;12(4): 233-244.
40. Armstrong K. Can genomics bend the cost curve? JAMA. 2012;307 (10): 1031-1032.
41. Ioannidis JP, Trikalinos TA, KhouryMJ. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol. 2006;164(7): 609-614.
42. Rockhill B. Theorizing about causes at the individual level while estimating effects at the population level: implications for prevention. Epidemiology. 2005;16(1): 124-129.